Syngene International Ltd. announced the establishment in Bangalore, India, of an integrated, multi-disciplinary drug discovery and development center for Amgen Inc. This center, named Syngene Amgen Research and Development Center (SARC), will be Syngene's fourth such exclusive R&D center. Syngene already operates R&D centers for Bristol-Myers Squibb, Abbott Nutrition and Baxter Inc. The center will be staffed by a team of more than 100 highly qualified Syngene scientists, working in close association with Amgen researchers around the world on the discovery and development of innovative medicines. In addition to being customized to meet Amgen's functional requirements, the facility complies with the regulatory standards. Its design includes a range of environmentally-friendly features and flexible layouts, and is configured to minimize solvent and effluent waste with a strong emphasis on laboratory safety and "green" chemistry.